MyFinsight
Home
About
Contact
mtnb: the income statement
Download
Download image
Net loss
attributable to common...
-$2,150K
Deemed dividend
relating to warrant...
-$618K
Net loss
-$1,532K
(64.16%↑ Y/Y)
Other
income/(expenses), net
$45K
(-57.55%↓ Y/Y)
Loss from operations
-$1,577K
(64.00%↑ Y/Y)
Total costs and
expenses
$1,577K
(-64.00%↓ Y/Y)
General and
administrative
$1,577K
(-26.38%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Matinas BioPharma Holdings, Inc. (MTNB)
Matinas BioPharma Holdings, Inc. (MTNB)